Menu
Gallery
Previous
Next
Overview
Putting Your Best Foot Forward
Foot Care Rx
“THIS PRODUCT WILL SERVE AS AN AMPUTATION PREVENTION PROTOCOL,
REDUCING DIABETIC FOOT SURGERY AND AMPUTATIONS BY 50%”
– Dr. Daniel Johnson
– Dr. Daniel Johnson
The Product
- Foot Care Rx machines provide an easy way for patients to have a simple diagnostic procedure done on their feet, at a fraction of the cost of a regular doctor’s visit.
- A trained health practitioner can identify any potential issues before they are critical and refer the patient for further treatment, thus avoiding the need for an amputation.
How it Works
Business Concept
- Franchise model – Foot Care Rx Machines will be licensed to qualified franchise partners
- Foot Care Rx Franchises are well suited to operate similar to a retail clinic
- Franchisees pay a 20% royalty on two revenue streams:
- Examination fee of $50 per patient visit
- Sales of Foot Care Rx Branded Medical supplies. Estimate an average $50 spend on supplies per patient visit
The Problem
- A number of common foot disorders are typically not addressed due to the high cost of healthcare.
- Many diabetic foot amputations could easily be avoidable if patients simply have regular checks by a health practitioner before complications occur.
- High risk individuals with chronic disorders such as arthritis, and vascular problems are also an underserved market.
- However, frequent visits to the doctor can be very expensive and time consuming.
The Solution
- A quick and affordable method for a patient to get a routine foot examination.
- A way for patients to identify and address foot issues before they become major problems.
- A way for patients to maintain proper foot health.
Use of Proceeds
The Use of Funds will e the buildout of ten (10) clinics based on the per clinic build-out cost below.
- Equipment: $24,000
- Renovations: $50,000
- Marketing: $15,000
- Licensing & Fees $50,000
- Operating Expenses: $61,000
Market Size
- Total Available Market (TAM) = 600,000 diabetic patients in the English Caribbean
- Serviceable Available Market (SAM) = approximately 11% of the TAM, or 65,000 patients
Our Strategy
Competitive Advantages
Financial Highlights
- Asking for financing to cover operations for first 3 years
- $2M for 20% equity ownership
- Projecting $4.5M in revenue by year 3
- Planning 20% dividend payout from year 3 onwards
FINANCIAL PROJECTIONS
Projected Statement of Profit & Loss
For the years ended December 31, 2022 - 2026
Projected Statement of Cash Flows
For the years ended December 31, 2022 - 2026
Projected Statement of Financial Position (Balance Sheet)
As at December 31, 2022 - 2026
Ratio Analysis on Projected Balances
As at and for the years ended December 31, 2022 - 2026
MEET THE FOOT CARE RX TEAM
Dr. Daniel Johnson, DPM, FPMS, FRCPS (Glasgow)
President of Foot and Ankle International and leading Podiatrist and Podiatric Surgeon with over 25 years of experience. Pioneering research, technology and techniques aimed at Amputation Prevention and surgical intervention in the Diabetic Foot. He implemented Project L.E.A.P. (Lower Extremity Amputation Prevention) in 1994 and holds directorships in the USA, the Caribbean and The Bahamas.
Immalasha Thompson
Ms. Cora Cooper
Mrs. Alicia Johnson
Comments
You must log in to comment.